Home
Cormorant Asset Management

Cormorant Asset Management Market Share Analysis for May 2026

Industry: N/A

Domaincormorant.com

Year Founded--

Employees51 - 200

Annual Revenue$25M - $50M

Cormorant Asset Management

Cormorant Asset Management (including company regionals)

cormorant.com

See more website traffic and engagement information

Cormorant Asset Management Revenue up to May 2026 is 25M - 50M

revenue generated by Cormorant Asset Management top domains

Cormorant Asset Management top domains revenue over 3 years

Revenue for Cormorant Asset Management top domains

cormorant.com25M - 50M

See more with Sales Intelligence

Total visits to Cormorant Asset Management's top domains

Understand Cormorant Asset Management market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Cormorant Asset Management's top domains

Analyze Cormorant Asset Management engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Cormorant Asset Management's top domains

See how Cormorant Asset Management keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Cormorant Asset Management top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Cormorant Asset Management

looks like we dont have enough data

No Data to Display

News & Signals from Cormorant Asset Management

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCormorant Asset Management invests into Aardvark Therapeutics, Inc. $85M.Aardvark Therapeutics has raised an $85 million oversubscribed Series C financing led by Decheng Capital, with participation from Cormorant Asset Management, Surveyor Capital, SymBiosis, Tetragon Financial Group, Walleye Capital, Laurion Capital Management, LG Technology Ventures, Cantor Ventures, Silver Arc Private Capital, The Prader-Willi Syndrome Association - USA, and existing investors, including Vickers Venture Partners and the Foundation for Prader-Willi Research.

NewsCormorant Asset Management invests into Neurona Therapeutics, Inc. $120M.Neurona Therapeutics, a biotherapeutics company focused on creating regenerative cell therapy for the treatment of neurological disorders, has secured $120 million in a funding round co-led by Viking Global Investors and Cormorant Asset Management, with participation from new and existing investors SymBiosis, Alexandria Venture Investments, Berkeley Frontier Fund and others.

NewsCormorant Asset Management invested into BiVACOR Inc. $18M on Mar 1st '23.In March 2023, Bivacor received $18 million in funding led by Boston-based Cormorant Asset Management and Australian venture capital firm OneVentures, through the OneVentures Healthcare Fund III.